Cargando…

Loss of heterozygosity: what is it good for?

BACKGROUND: Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be involved in the somatic loss of wild-type alleles in many inherited cancer syndromes. The wider involvement of LOH in cancer is assumed to relate to unmasking a somatically mutated tumour sup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryland, Georgina L., Doyle, Maria A., Goode, David, Boyle, Samantha E., Choong, David Y.H., Rowley, Simone M., Li, Jason, Bowtell, David DL, Tothill, Richard W., Campbell, Ian G., Gorringe, Kylie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522148/ https://www.ncbi.nlm.nih.gov/pubmed/26231170 http://dx.doi.org/10.1186/s12920-015-0123-z

Ejemplares similares

MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers
por: Ryland, Georgina L., et al.
Publicado: (2012)

Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer
por: Davis, Sally J, et al.
Publicado: (2011)

A simple consensus approach improves somatic mutation prediction accuracy
por: Goode, David L, et al.
Publicado: (2013)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015)

Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017)

CONTRA: copy number analysis for targeted resequencing
por: Li, Jason, et al.
Publicado: (2012)

Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue
por: Kader, Tanjina, et al.
Publicado: (2016)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles
por: Thompson, Ella R., et al.
Publicado: (2012)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
por: Lung, Mei Sim, et al.
Publicado: (2020)

Females prefer the scent of outbred males: good-genes-as-heterozygosity?
por: Ilmonen, Petteri, et al.
Publicado: (2009)

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
por: Li, Na, et al.
Publicado: (2018)

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
por: Etemadmoghadam, Dariush, et al.
Publicado: (2010)

Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment
por: Li, Jason, et al.
Publicado: (2014)

Genomic loss of heterozygosity and survival in the REAL3 trial
por: Smyth, Elizabeth C., et al.
Publicado: (2018)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Loss of Heterozygosity Drives Adaptation in Hybrid Yeast
por: Smukowski Heil, Caiti S., et al.
Publicado: (2017)

Correction: Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis
por: Ramakrishna, Manasa, et al.
Publicado: (2011)

Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis
por: Ramakrishna, Manasa, et al.
Publicado: (2010)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.
por: Foulkes, W. D., et al.
Publicado: (1993)

Genome plasticity driven by aneuploidy and loss of heterozygosity in Trypanosoma cruzi
por: Cruz-Saavedra, Lissa, et al.
Publicado: (2022)

Loss of heterozygosity of the oestrogen receptor gene in breast cancer.
por: Iwase, H., et al.
Publicado: (1995)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
por: Kader, Tanjina, et al.
Publicado: (2020)

Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas.
por: Viel, A., et al.
Publicado: (1997)

Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma
por: Bustamante, Bethany, et al.
Publicado: (2021)

Compound heterozygosity for hemoglobin S and D: what do we need to know?()
por: Bonini-Domingos, Claudia Regina
Publicado: (2016)

Loss of heterozygosity of TRIM3 in malignant gliomas
por: Boulay, Jean-Louis, et al.
Publicado: (2009)

Analysis of Loss of Heterozygosity in Korean Patients with Keratoacanthoma
por: Ha, Tae-Won, et al.
Publicado: (2005)

Targeting tumor vulnerabilities associated with loss of heterozygosity
por: Rendo, Veronica, et al.
Publicado: (2020)

Fitness benefits of loss of heterozygosity in Saccharomyces hybrids
por: Lancaster, Samuel M., et al.
Publicado: (2019)

Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021)

Polyploidy as an Adaptation against Loss of Heterozygosity in Cancer
por: Archetti, Marco
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03s1qfecgvar4um7vu7e10fn1u